- Home
- BCBP vs MCRB Comparison
BCBP vs MCRB Comparison
Compare BCBP & MCRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCBP
- MCRB
- Stock Information
- Founded
- BCBP 2000
- MCRB 2010
- Country
- BCBP United States
- MCRB United States
- Employees
- BCBP N/A
- MCRB N/A
- Industry
- BCBP Savings Institutions
- MCRB Biotechnology: Pharmaceutical Preparations
- Sector
- BCBP Finance
- MCRB Health Care
- Exchange
- BCBP Nasdaq
- MCRB Nasdaq
- Market Cap
- BCBP 170.1M
- MCRB 141.9M
- IPO Year
- BCBP N/A
- MCRB 2015
- Fundamental
- Price
- BCBP $9.46
- MCRB $0.37
- Analyst Decision
- BCBP Hold
- MCRB Hold
- Analyst Count
- BCBP 2
- MCRB 5
- Target Price
- BCBP $13.38
- MCRB $4.00
- AVG Volume (30 Days)
- BCBP 53.7K
- MCRB 1.3M
- Earning Date
- BCBP 04-29-2025
- MCRB 05-07-2025
- Dividend Yield
- BCBP 6.74%
- MCRB N/A
- EPS Growth
- BCBP N/A
- MCRB N/A
- EPS
- BCBP 0.99
- MCRB 0.00
- Revenue
- BCBP $83,391,000.00
- MCRB N/A
- Revenue This Year
- BCBP $26.80
- MCRB N/A
- Revenue Next Year
- BCBP $9.82
- MCRB N/A
- P/E Ratio
- BCBP $9.62
- MCRB $474.36
- Revenue Growth
- BCBP N/A
- MCRB N/A
- 52 Week Low
- BCBP $8.66
- MCRB $0.46
- 52 Week High
- BCBP $14.04
- MCRB $1.53
- Technical
- Relative Strength Index (RSI)
- BCBP 45.64
- MCRB 28.34
- Support Level
- BCBP $8.77
- MCRB $0.36
- Resistance Level
- BCBP $10.05
- MCRB $0.67
- Average True Range (ATR)
- BCBP 0.47
- MCRB 0.07
- MACD
- BCBP 0.00
- MCRB -0.02
- Stochastic Oscillator
- BCBP 57.55
- MCRB 2.71
About BCBP BCB Bancorp Inc. (NJ)
BCB Bancorp Inc is a bank holding company. The company offers loans, including commercial and multi-family real estate loans, home equity loans, construction loans, consumer loans, and commercial business loans; FDIC-insured deposit products, such as savings and club accounts, interest and non-interest bearing demand accounts, money market accounts, certificates of deposit and individual retirement accounts, and retail and commercial banking services, including wire transfers, money orders, safe deposit boxes, a night depository, debit cards, online banking, gift cards, fraud detection and automated teller services.
About MCRB Seres Therapeutics Inc.
Seres Therapeutics Inc is a microbiome therapeutics platform company operating in the United States. The company is engaged in developing biological drugs which are referred as ecobiotic microbiome therapeutics. The drugs discovered by the company are designed to restore health by repairing the function of a dysbiotic microbiome. The company focuses on implementing its microbiome therapeutics platform to develop ecobiotic microbiome therapeutics that treat dysbiosis in the colonic microbiome. SER-109, the company's product, is designed to prevent further recurrences of Clostridium difficile infection (CDI), a debilitating infection of the colon. In addition, the company is involved in developing SER-262, SER-287, and SER-401.